TABLE 6.

ROC curve-predicted sensitivity at fixed specificity^a

Test kit	Fixed specificity
	99%		98%		97%		96%		95%		90%
	%	P	%	P	%	P	%	P	%	P	%	P
BioPlex 2200 Lyme Total	91.1	Ref	91.1	Ref	91.1	Ref	92.2	Ref	92.2	Ref	95.6	Ref
Immunetics Lyme C6	82.2	0.008	83.3	0.016	86.7	0.125	86.7	0.063	86.7	0.063	88.9	0.031
Zeus Borrelia VlsE1/pepC10	76.7	<0.001	84.4	0.031	84.4	0.031	86.7	0.063	87.8	0.125	88.9	0.031
bioMérieux VIDAS Lyme polyvalent	47.8	<0.001	71.1	<0.001	74.4	<0.001	75.6	<0.001	75.6	<0.001	82.2	0.002
bioMérieux VIDAS Lyme II (lgM+IgG)	77.8	<0.001	77.8	<0.001	77.8	<0.001	80.0	0.001	80.0	0.001	83.3	0.001
bioMérieux VIDAS Lyme II lgM	50.0	<0.001	50.0	<0.001	52.2	<0.001	57.8	<0.001	58.9	<0.001	67.8	<0.001
bioMérieux VIDAS Lyme II lgG	77.8	<0.001	84.4	0.031	84.4	0.031	84.4	0.016	84.4	0.016	84.4	0.002

^aThe ROC curves generated in Fig. 1 were used to measure the predicted sensitivity of the Lyme assays at the selected specificity levels shown. Ref, reference.